INFLUX logo

Influx Healthtech Limited

INFLUX·NSE·
290.10 -3.25 (-1.11%)
Market Cap703.54 Cr
PE Ratio39.36
Volume20,400
Day High - Low297.50 - 290.10
52W High-Low315.00 - 160.60
DocStoX Score
6.5/10
Fair
Fair Value
Sign in to see
ROE
30.00%
Strong
P/E
39.36x
Expensive
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day290.10
297.50
52W160.60
315.00
DocStoX take

Supported by growth (8.5) and risk (8.3), but held back by valuation (0.9). Growth looks strong at 8.5, but that is offset by valuation at 0.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.5
/10
Fair
Quality
Excellent
ROE 30.0%
Valuation
Expensive
P/E 39.4×
Growth
Strong
Revenue +24.6% 3Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Strong
84% of 52-week range

At a glance

Market Cap
₹704 Cr
52W High / Low
₹315 / ₹161
Dividend Yield
0.00%
Promoter Holding
73.53%
EPS (TTM)
₹7.37
Book Value
₹43.52

Key highlights

  • Capital works hard — ROCE 60%
  • Profit compounding 42% a year
  • Strong returns on equity (30%)
  • Valuation is weak (0.9/10)
  • Small ₹704 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

INFLUX HEALTHTECH LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.